(Q41344551)

29 September 2017

Interleukin-6 (IL-6) antagonism by soluble IL-6 receptor alpha mutated in the predicted gp130-binding interface (English)

1 reference

29 September 2017

4

1 reference

29 September 2017

Salvati AL

1

1 reference

29 September 2017

Lahm A

series ordinal

2

1 reference

29 September 2017

Paonessa G

series ordinal

3

1 reference

29 September 2017

Toniatti C

series ordinal

5

1 reference

29 September 2017

language of work or name

English

0 references

publication date

1 May 1995

1 reference

Journal of Biological Chemistry

29 September 2017

1 reference

29 September 2017

270

1 reference

29 September 2017

12242-12249

1 reference

29 September 2017

20

1 reference

Cytokine signal transduction

29 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

Molecular cloning and expression of an IL-6 signal transducer, gp130

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

Expression of the murine interleukin 6 receptor in hepatoma cells: the intracytoplasmic domain is not required for interleukin 6 signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

Human growth hormone and extracellular domain of its receptor: crystal structure of the complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

Multimeric cytokine receptors: common versus specific functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

Rational design of potent antagonists to the human growth hormone receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

Structural and functional basis for hormone binding and receptor oligomerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

The Protein Data Bank: a computer-based archival file for macromolecular structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

WHAT IF: a molecular modeling and drug design program

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

Structure of a Fibronectin Type III Domain from Tenascin Phased by MAD Analysis of the Selenomethionyl Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

A general method for rapid site-directed mutagenesis using the polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

Production and structural characterization of amino terminally histidine tagged human oncostatin M in E. coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

Functional murine interleukin 6 receptor with the intracisternal A particle gene product at its cytoplasmic domain. Its possible role in plasmacytomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

Recombinant soluble human interleukin-6 receptor. Expression in Escherichia coli, renaturation and purification

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

Saturation mutagenesis of the human interleukin 6 receptor-binding site: implications for its three-dimensional structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

Development of an interleukin (IL) 6 receptor antagonist that inhibits IL-6-dependent growth of human myeloma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

Protective effect of anti-interleukin (IL)-6 antibody against endotoxin, associated with paradoxically increased IL-6 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

High amounts of circulating interleukin (IL)-6 in the form of monomeric immune complexes during anti-IL-6 therapy. Towards a new methodology for measuring overall cytokine production in human in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

Structural design and molecular evolution of a cytokine receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

In a staphylococcal nuclease mutant the side-chain of a lysine replacing valine 66 is fully buried in the hydrophobic core

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

Differential shedding of the two subunits of the interleukin-6 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.20.12242

21 January 2018

Identifiers

DOI

10.1074/JBC.270.20.12242

1 reference

release_yonprvhekngrpozwi6ce5ufjsy

29 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yonprvhekngrpozwi6ce5ufjsy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference